Grace Therapeutics

Grace Therapeutics

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-2
-4
EBITDA
-2,138
-15,788
-3,008
-3,357
EBIT
-2,139
-15,790
-3,010
-3,360
Net Income
-2,131
-15,790
-1,178
-3,176
Net Change In Cash
0
0
0
0
Free Cash Flow
-1,784
-3,221
-1,706
-2,218
Cash
21,311
13,756
16,977
18,672
Basic Shares
20,116
17,269
16,510
16,933

Annual Financials

Values in thousands2026-03-312025-03-312024-03-312023-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-6
-7
-11
-124
EBITDA
-11,070
-23,745
-15,414
-24,555
EBIT
-11,077
-23,752
-15,425
-24,679
Net Income
-7,793
-13,625
-17,441
-57,386
Net Change In Cash
0
0
0
0
Free Cash Flow
-8,869
-14,904
-12,355
-15,930
Cash
16,977
22,133
23,005
27,875
Basic Shares
16,510
12,087
9,529
7,435

Earnings Calls

QuarterEPS
2026-09-30
-$0.11
2026-06-30
-$0.91
2026-03-31
-$0.08
2025-12-31
-$0.19